These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31348077)

  • 1. Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
    Tulbah RI; Rowe SP; Solnes LB; Javadi MS
    Clin Nucl Med; 2019 Sep; 44(9):e519-e521. PubMed ID: 31348077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case 286: Sarcoidlike Granulomatosis and Lymphadenopathy-Thoracic Manifestations of Nivolumab Drug Toxicity.
    Chiang J; Hebroni F; Bedayat A; Pourzand L
    Radiology; 2021 Feb; 298(2):471-475. PubMed ID: 33493088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
    Yang H; Numani S; Liu S
    Clin Nucl Med; 2017 Jul; 42(7):e337-e339. PubMed ID: 28240658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab-Induced Pneumonitis in Patient With Metastatic Melanoma Showing Complete Remission on 18F-FDG PET/CT.
    Razzouk-Cadet M; Picard A; Grangeon-Chapon C; Lacour JP; Montaudié H
    Clin Nucl Med; 2019 Oct; 44(10):806-807. PubMed ID: 31306191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis.
    Lu Y
    Clin Nucl Med; 2019 Feb; 44(2):167-168. PubMed ID: 30516667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.
    Laroche A; Alarcon Chinchilla E; Bourgeault E; Doré MA
    J Cutan Med Surg; 2018; 22(6):627-629. PubMed ID: 29772919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiorgan Involvement of Chemotherapy-Induced Sarcoidosis Mimicking Progression of Lymphoma on FDG PET/CT.
    Sanan P; Lu Y
    Clin Nucl Med; 2017 Sep; 42(9):702-703. PubMed ID: 28632694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of integrated FDG-PET/CT in sarcoidosis.
    Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
    Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab.
    González-Cruz C; Bodet D; Muñoz-Couselo E; García-Patos V
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab-Induced Subcutaneous Fat Necrosis: Another FDG-Avid Immune-Related Adverse Event.
    Bhargava P; Flynt L; Marcal L
    Clin Nucl Med; 2020 Feb; 45(2):125-126. PubMed ID: 31789905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ; Lee VK; Loo SW
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.
    Danlos FX; Pagès C; Baroudjian B; Vercellino L; Battistella M; Mimoun M; Jebali M; Bagot M; Tazi A; Lebbé C
    Chest; 2016 May; 149(5):e133-6. PubMed ID: 27157227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary sarcoid-like granulomatosis induced by nivolumab.
    Montaudié H; Pradelli J; Passeron T; Lacour JP; Leroy S
    Br J Dermatol; 2017 Apr; 176(4):1060-1063. PubMed ID: 27291635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
    Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
    Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy.
    Tan I; Malinzak M; Salama AKS
    J Immunother Cancer; 2018 Jul; 6(1):77. PubMed ID: 30064495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
    Firwana B; Ravilla R; Raval M; Hutchins L; Mahmoud F
    J Oncol Pharm Pract; 2017 Dec; 23(8):620-624. PubMed ID: 27590328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
    Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.